NSN Co. Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.143x

NSN Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, NSN Co. Ltd (031860) has a cash flow conversion efficiency ratio of -0.143x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.89 Billion ≈ $-1.96 Million USD) by net assets (₩20.26 Billion ≈ $13.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of NSN Co. Ltd (2014–2025)

Cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2025. This chart illustrates how NSN Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NSN Co. Ltd share price for real-time trading data and today's change.

NSN Co. Ltd Cash Flow Conversion Ratio Explained

NSN Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

NSN Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NSN Co. Ltd ranked by their cash flow conversion efficiency. Also see NSN Co. Ltd (031860) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Vigor Kobo Co Ltd
TWO:2733
-0.016x
Prima Globalindo Logistik Tbk
JK:PPGL
0.060x
Park Ha Biological Technology Co., Ltd.
NASDAQ:BYAH
N/A
IDeA Indonesia Akademi Tbk PT
JK:IDEA
0.034x
Torrent Capital Ltd
V:TORR
0.075x
COINSILIUM GROUP LTD
F:5CT
N/A
Scibase AB
ST:SCIB
-0.457x
Optimi Health Corp. Common Shares
NASDAQ:OPTH
-0.162x

Annual Cash Flow Conversion Efficiency for NSN Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2025. Review NSN Co. Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩20.26 Billion
≈ $13.73 Million
₩-8.86 Billion
≈ $-6.01 Million
-0.437x -274.65%
2024-12-31 ₩48.12 Billion
≈ $32.61 Million
₩-5.62 Billion
≈ $-3.81 Million
-0.117x +12.82%
2023-12-31 ₩59.75 Billion
≈ $40.49 Million
₩-8.00 Billion
≈ $-5.42 Million
-0.134x +29.67%
2022-12-31 ₩59.58 Billion
≈ $40.38 Million
₩-11.35 Billion
≈ $-7.69 Million
-0.190x +40.54%
2021-12-31 ₩38.49 Billion
≈ $26.08 Million
₩-12.33 Billion
≈ $-8.35 Million
-0.320x -266.26%
2020-12-31 ₩51.00 Billion
≈ $34.56 Million
₩-4.46 Billion
≈ $-3.02 Million
-0.087x +54.68%
2019-12-31 ₩22.70 Billion
≈ $15.38 Million
₩-4.38 Billion
≈ $-2.97 Million
-0.193x +32.29%
2018-12-31 ₩18.37 Billion
≈ $12.45 Million
₩-5.23 Billion
≈ $-3.55 Million
-0.285x +29.34%
2017-12-31 ₩20.42 Billion
≈ $13.84 Million
₩-8.24 Billion
≈ $-5.58 Million
-0.403x -46.84%
2016-12-31 ₩22.41 Billion
≈ $15.18 Million
₩-6.15 Billion
≈ $-4.17 Million
-0.275x +1.90%
2015-12-31 ₩23.86 Billion
≈ $16.17 Million
₩-6.68 Billion
≈ $-4.53 Million
-0.280x -229.13%
2014-12-31 ₩29.52 Billion
≈ $20.00 Million
₩-2.51 Billion
≈ $-1.70 Million
-0.085x --

About NSN Co. Ltd

KQ:031860 Korea Diagnostics & Research
Market Cap
$12.68 Million
₩18.71 Billion KRW
Market Cap Rank
#26299 Global
#1979 in Korea
Share Price
₩693.00
Change (1 day)
+17.26%
52-Week Range
₩265.00 - ₩802.00
All Time High
₩146500.00
About

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more